What is NOEM's issuance of warrants?

NOEM (NOEM) reported issuance of warrants of $51.75K in Q4 2024.

What does issuance of warrants mean?

Captures the financial impact of issuing warrants, which provide holders the right to purchase stock at a specified price. This metric helps investors track potential future dilution and the cost of equity-linked financing arrangements.

NOEM NOEM Issuance of warrants

Issuance of warrants at other companies

Oruka Therapeutics, Inc.ORKA

$2.52M-75.7%

Ispire Technology Inc.ISPR

$91.49K—

SVC

Stellar V Capital Corp. Class A Ordinary SharesSVCC

$1.22M—

Evommune EVMN

$150—

CO2 Energy Transition Corp. Common StockNOEM

$51.75K—

ADMA BiologicsADMA

$1.4M—

Other financials

Income statement

See full

Operating income-$196.7K-15.2%

Net income$309.2K-23.9%

EPS (diluted)-$0.01—

Balance sheet

See full

Cash & equivalents$26.1K-95.9%

Total debt$11.7K—

Total equity-$2.0M-33.3%

Total assets$72.1M+1.7%

Cash flow

See full

Operating cash flow-$1.1M-237%

Valuation

See full

Market cap$100.08M+3.5%

P/E64.4×-47.0×

Returns & leverage

See full

Return on equity-90.8%—

Current ratio2.6×+0.7×

Where this comes from

Reported directly by NOEM in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.

The official record: NOEM’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about NOEM's issuance of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NOEM's issuance of warrants?: NOEM (NOEM) reported issuance of warrants of $51.75K in Q4 2024.
What does issuance of warrants mean?: Captures the financial impact of issuing warrants, which provide holders the right to purchase stock at a specified price. This metric helps investors track potential future dilution and the cost of equity-linked financing arrangements.